Kinnate Biopharma Inc
NASDAQ:KNTE
Income Statement
Earnings Waterfall
Kinnate Biopharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-119m
USD
|
Operating Income
|
-119m
USD
|
Other Expenses
|
6.4m
USD
|
Net Income
|
-112.6m
USD
|
Income Statement
Kinnate Biopharma Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(53)
|
(78)
|
(90)
|
(100)
|
(106)
|
(112)
|
(119)
|
(126)
|
(133)
|
(133)
|
(119)
|
|
Selling, General & Administrative |
(12)
|
(18)
|
(23)
|
(26)
|
(28)
|
(30)
|
(30)
|
(31)
|
(31)
|
(30)
|
(28)
|
|
Research & Development |
(41)
|
(60)
|
(67)
|
(74)
|
(78)
|
(83)
|
(88)
|
(95)
|
(102)
|
(103)
|
(91)
|
|
Operating Income |
(53)
N/A
|
(78)
-47%
|
(90)
-16%
|
(100)
-11%
|
(106)
-6%
|
(112)
-6%
|
(119)
-6%
|
(126)
-6%
|
(133)
-5%
|
(133)
+0%
|
(119)
+10%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
|
Total Other Income |
(1)
|
(1)
|
0
|
(1)
|
0
|
1
|
2
|
4
|
6
|
7
|
9
|
|
Pre-Tax Income |
(53)
N/A
|
(77)
-47%
|
(90)
-16%
|
(99)
-11%
|
(105)
-6%
|
(111)
-6%
|
(116)
-5%
|
(122)
-5%
|
(127)
-4%
|
(127)
+0%
|
(113)
+11%
|
|
Net Income | ||||||||||||
Income from Continuing Operations |
(53)
|
(77)
|
(90)
|
(99)
|
(105)
|
(111)
|
(116)
|
(122)
|
(127)
|
(127)
|
(113)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(53)
N/A
|
(77)
-47%
|
(90)
-16%
|
(99)
-11%
|
(105)
-6%
|
(111)
-6%
|
(116)
-5%
|
(122)
-5%
|
(127)
-4%
|
(127)
+0%
|
(113)
+11%
|
|
EPS (Diluted) |
-1.21
N/A
|
-1.78
-47%
|
-2.06
-16%
|
-2.27
-10%
|
-2.4
-6%
|
-2.53
-5%
|
-2.64
-4%
|
-2.69
-2%
|
-2.72
-1%
|
-2.7
+1%
|
-2.42
+10%
|